Skip to main content
Clinical Trials/CTRI/2020/12/030069
CTRI/2020/12/030069
Not yet recruiting
未知

To evaluate the effect of Hyoscine N Butyl Bromide ( HNBB) on the progress of labour in term pregnancies in a tertiary care institute

Dr Arularasan J0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Arularasan J
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Arularasan J

Eligibility Criteria

Inclusion Criteria

  • Primigravida and Multigravida
  • \- Gestational age of 37 completed weeks to 41 weeks
  • \- Live singleton pregnancy
  • \- Cephalic presentation
  • \- In active phase of labour
  • \- Membranes intact or ruptured ( PROM \<12 hours)

Exclusion Criteria

  • \- Patients having contraindications for usage of HNBB such as Myasthenia Gravis, Narrow angle glaucoma
  • \- Multiple pregnancies
  • \- conditions where there are Previous Uterine scars
  • \- Malpresentation
  • \- Cephalo pelvic dispropotion
  • \- Antepartum hemorrhage
  • \- Medical disorders complicating pregnancies such as severe anemia, cardiac diseases, hypertensive disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials